PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.15%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
5.86%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
12.81%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
12.93%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
-13.39%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-13.40%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.40%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-2.38%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-2.38%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
157.75%
Similar 10Y revenue/share CAGR to 3141.T's 147.24%. Walter Schloss might see both firms benefiting from the same long-term demand.
57.39%
5Y revenue/share CAGR similar to 3141.T's 56.56%. Walter Schloss might see both companies benefiting from the same mid-term trends.
27.75%
3Y revenue/share CAGR similar to 3141.T's 28.41%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
108.53%
Net income/share CAGR above 1.5x 3141.T's 45.63% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
33.23%
5Y net income/share CAGR 1.25-1.5x 3141.T's 22.58%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-13.11%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
353.50%
10Y equity/share CAGR above 1.5x 3141.T's 235.49%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
90.72%
5Y equity/share CAGR 1.25-1.5x 3141.T's 66.26%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
41.66%
3Y equity/share CAGR 1.25-1.5x 3141.T's 32.65%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.07%
AR growth well above 3141.T's 4.57%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.03%
Inventory shrinking or stable vs. 3141.T's 7.50%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
3.36%
Asset growth above 1.5x 3141.T's 1.66%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.00%
Positive BV/share change while 3141.T is negative. John Neff sees a clear edge over a competitor losing equity.
-33.66%
We’re deleveraging while 3141.T stands at 7.66%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
83.99%
SG&A growth well above 3141.T's 0.77%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.